πŸ‡ΊπŸ‡Έ FDA
Patent

US 9610261

Methods of treating Prader-Willi Syndrome

granted A61KA61K31/145

Quick answer

US patent 9610261 (Methods of treating Prader-Willi Syndrome) held by OVID THERAPEUTICS INC. expires Mon Mar 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
OVID THERAPEUTICS INC.
Grant date
Tue Apr 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/145